Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Reductive Amination Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Cu-Ni catalyzed solvent-free method for tris(3,6-dioxaheptyl)amine. High yield, low impurities. Cost-effective phase-transfer catalyst production.
Patent CN112194585A reveals a high-yield reductive amination route for Bromhexine Hydrochloride, eliminating corrosive thionyl chloride and enhancing supply chain stability.
Patent CN110551032B details a high-efficiency iridium-catalyzed asymmetric reductive amination method, offering significant cost reduction in agrochemical manufacturing and reliable supply chain solutions.
Novel Lewis acid catalyzed reductive amination route offers >99% purity and scalable production for pharmaceutical intermediates.
Patent CN110668976A reveals a novel Ir-catalyzed asymmetric synthesis for (R)-Rivastigmine intermediates, offering superior yield and purity for reliable pharmaceutical supply chains.
Patent CN101857593A discloses a novel reductive amination route for 9-aminoquinine derivatives, offering high purity and scalable production for pharmaceutical applications.
Advanced preparation of Maropitant intermediates via transition metal catalysis. High purity, >99% ee, and scalable routes for pharmaceutical manufacturing.
Discover the novel ternary catalyst method for N-ethyl-D-glucosamine production. Achieve higher purity and yield while reducing manufacturing costs and supply chain risks.
Patent CN110862324A discloses a novel iridium-catalyzed asymmetric reductive amination method achieving up to 95% ee for key pharmaceutical intermediates like Cinacalcet.
Patent CN103951588A reveals a novel chiral squaramide catalytic route for saxagliptin intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN110551033B details a novel Ir-catalyzed asymmetric reductive amination method. Achieve high enantioselectivity and cost reduction in chiral amine manufacturing with scalable processes.
Advanced synthesis of 2-methoxy-4-methylbenzylamine via safe reductive amination. Offers significant cost reduction in fine chemical manufacturing and high purity.
Novel reductive amination route for bromhexine hydrochloride offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners.
Novel N,N-coordinated rhodium complex enables high-yield reductive amination. Offers supply chain stability and cost reduction in pharmaceutical intermediate manufacturing.